epoetin alfa
- Generic Name
- epoetin alfa
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not Applicable
Completed
- Conditions
- HIV InfectionsCytopenias
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Ortho Pharmaceuticals
- Registration Number
- NCT00002072
- Locations
- 🇺🇸
Ortho Pharmaceutical Corp, Raritan, New Jersey, United States
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not Applicable
Completed
- Conditions
- CytopeniasHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Ortho Pharmaceuticals
- Registration Number
- NCT00002073
- Locations
- 🇺🇸
Ortho Pharmaceutical Corp, Raritan, New Jersey, United States
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
Phase 2
Completed
- Conditions
- Beta-Thalassemia
- First Posted Date
- 2000-08-04
- Last Posted Date
- 2005-11-08
- Lead Sponsor
- Boston University
- Target Recruit Count
- 15
- Registration Number
- NCT00006136
- Locations
- 🇬🇧
University College London, London, England, United Kingdom
🇺🇸Children's Hospital of Oakland, Oakland, California, United States
🇺🇸Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath